69 results about "Diagnostic Test Result" patented technology

Testing methods and systems provide a Diagnostic Testing Service as well as an attack simulation service, for a perimeter security system, in a non-disruptive manner, so that the production targets can be tested while normally functioning, and do not have to be brought down for testing. The testing methods can be implemented, such that they are vendor and device type neutral, considering the overall strategy utilized to prevent perimeter security system attacks.

Systems and methods include an Information Handling System (IHS) that is adapted to diagnose root causes of issues reported by hardware and / or software of the IHS. Telemetry is monitored that specifies operating status information for hardware components of the IHS. Stress event are detected that are related to the hardware components. One or more stress tests are identified for evaluation of each hardware component that is related to stress event. While monitoring the telemetry, the stress tests are conducted in order to replicate the detected stress event. When the detected stress event is replicated, a root cause hardware component of the IHS is determined based on machine learning evaluation of the telemetry generated during replication of the stress event.

This invention belongs to the field of diagnostic testing technology. Addressing the problem that existing gestational diabetes screening methods may miss the optimal time for early intervention, leading to the failure to promptly detect and manage some potentially hyperglycemic pregnant women, increasing the risk of adverse maternal and fetal outcomes, this invention proposes a plasma metabolic biomarker for the early diagnosis or prediction of gestational diabetes and its application. This plasma metabolic biomarker is at least one of L-lysine, propargylglycine, N6-acetyl-L-lysine, cyclic leucine, and glycine-deoxycholic acid. The five plasma metabolic biomarkers provided by this invention can be applied to the early diagnosis or prediction of gestational diabetes, and are of great significance for the prevention or treatment of gestational diabetes.

An automated apparatus can provide pre-analytical processing of samples, racking and forwarding to an adjacent analyzer for analysis. The apparatus may have a controller that implements an auto-learn process to teach robotic handlers the locations within the workspace(s) of the apparatus. A robotic sample handler may include a sensor configured to generate a detection signal when in a near vicinity of a fiducial beacon in the workspace of the apparatus for biological sample preparation, preprocessing and / or diagnostic assay performed by one or more analyzers of the automated apparatus. The controller may control the robotic sample handler to conduct a search pattern so that a location of the fiducial beacon may be detected and thereafter calculated to obtain a more accurate location of the beacon. The calculated positions may then serve as a basis for the controlled movement of samples by the robot to and from locations of the workspace.

The present disclosure relates to techniques for preprocessing samples and using preprocessed samples and machine learning models to predict clinical diagnostic tests for a patient from their historical laboratory testing data. Particularly, aspects are directed to obtaining datasets including features and / or historical laboratory test results for subjects, filtering the datasets based on a denoise-balance scheme to obtain filtered datasets, training a machine learning model using the filtered datasets to obtain a trained machine learning model, and providing the trained machine learning model. A candidate machine learning model may be an ensemble of classifiers implemented with a boosting algorithm, and the ensemble is trained by applying base machine learning algorithms on different distributions of the filtered datasets. The ensemble is then combined into a machine learning model having the set of learned model parameters for predicting results for clinical diagnostic tests.

EMBEDDED ML VLSI DATA PROCESSING DEVICE FOR REAL-TIME PROCESSING AND DIAGNOSTIC TESTING

Disclosed is a test system (100) comprising a test apparatus (100, 400). The test apparatus includes a pool (102) having a volume and an inlet (106, 408) for filling the volume with a test fluid (108, 414). An inner surface (114) of the pool comprises an amount of a viscosity modifying reagent (110, 410) in a dried format. The system also includes an immunochromatography assay strip (104, 502). The viscosity modifying reagent comprises a viscosity-removing salt. The salt is configured to precipitate a viscosity-causing substance present in the test fluid. The immunochromatography assay strip is to be entered through the inlet to be in contact with the test fluid, when in use. The system facilitates processing of viscous fluids such as saliva for rapid diagnostic testing using lateral flow-based assays.

A diagnostic device, a diagnostic method, and a component supply device capable of simply and quickly diagnosing a component supply device. A diagnostic device for a tape feeder (2) that drives a conveyance mechanism for a component supply tape by means of a motor (23) is provided with a diagnostic unit. The tape feeder has an encoder (27) that detects rotation of an output shaft (a motor shaft (23J)) of the motor, and a feeder control unit (40) that receives a feedback signal (FS) from the encoder and controls the motor. The feeder control unit includes a motor drive unit (42) that supplies power to the motor with a pulse of a fixed period, and a feedback unit (41b) that outputs to the motor drive unit (42) a command value (secondary command (S2)) that adjusts the width of the pulse output by the motor drive unit on the basis of a feedback signal (FS). The diagnosis unit diagnoses the state of the tape feeder on the basis of a command value (secondary command (S2)) acquired from the tape feeder.

The invention provides an AI-based system for real-time scheduling and automated rescheduling of diagnostic testing appointments across a network of clinics. The system dynamically assigns appointments based on clinic availability, patient location, test urgency, and insurance compatibility. It incorporates a self-learning AI model trained on historical appointment and wait time data to optimize scheduling predictions and improve clinic throughput. A real-time monitoring module continuously tracks clinic conditions and triggers automated notifications when projected delays exceed a predefined threshold. Patients are offered options to remain at the original clinic, reschedule to a nearby clinic with shorter wait times, or cancel the appointment. The system includes a dual-view clinic interface (map and list), handles both integrated and non-integrated clinics, and ensures HIPAA-compliant handling of personal and health data. Integration with external clinic scheduling systems allows seamless data transfer and real-time synchronization. This invention significantly improves patient experience and clinic efficiency by reducing wait times and minimizing manual rescheduling efforts.

In some embodiments, a method of operating a plurality of diagnostic engines is provided. The method of operating includes receiving, via an instrument data manager (IDM) in communication with a plurality of diagnostic engines, a selection of one of the plurality of diagnostic engines for testing a sample of a patient; employing the IDM to disable at least one of the plurality of diagnostic engines that was not selected; prior to displaying a test result from the selected diagnostic engine for the sample of the patient, requiring entry of at least one of patient information and sample information; and after receiving entry of the patient information or sample information, employing the IDM to enable any disabled diagnostic engine. Numerous other embodiments are provided.

The invention relates to the field of automobile electronic testing, in particular to a diagnostic testing system, and aims to realize efficient, accurate and automatic testing of an automobile electronic system. The system comprises a test case generation module used for generating a test case corresponding to a target test task; the test execution module is used for running the test case according to a pre-written test script, executing the target test task and testing the automobile control unit; the test process optimization module is used for dynamically adjusting the execution sequence of the test steps of the test execution module according to a test process strategy; the diagnosis data analysis module is used for processing diagnosis response data obtained in the testing process and carrying out fault positioning; and the control and decision module is used for controlling and deciding the test process of the target task based on the processing results of the other modules.

Managing diagnostic testing of computing hardware, including: identifying a particular computing hardware for performing a diagnostic test at, the particular computing hardware associated with a shared library; receiving telemetry data associated with the particular computing hardware; determining that the telemetry data indicates a possible security event associated with the particular computing hardware, and in response: providing data indicating the shared library to a third-party vulnerability scanning service; receiving, from the third-party vulnerability scanning service, data indicating a security vulnerability of the shared library, and in response: identifying a diagnostic test that is implemented at the particular computing hardware via side band communication channel of the particular computing hardware; implementing, through the side band communication channel, the diagnostic test at the particular computing hardware; determining that the diagnostic test failed at the particular computing device, and in response, performing, independent of user action, a corrective action at the particular computing hardware.

This application relates to the field of diagnostic testing of electronic control units (ECUs), and discloses a diagnostic testing method and apparatus for ECUs. The method includes: obtaining a structured diagnostic process configuration file, the configuration file defining a sequence of diagnostic steps including at least one user data injection point and data filling rules corresponding to the injection point; in response to executing the diagnostic step sequence to reach the user data injection point, obtaining external data input by the user; and dynamically filling the external data into a specified position of the diagnostic message to be sent according to the data filling rules. This application solves the problem of rigid automated diagnostic testing processes that cannot be compatible with dynamic data input at runtime, and achieves a flexible unification of automated testing processes and user dynamic input requirements. It maintains the consistency of automated execution while improving the reusability and adaptability of testing tools to different testing scenarios.

The application discloses a storage device testing method and an electronic device, and relates to the field of computers. When a new engineering change notification event is monitored, a corresponding target event document is acquired. A preset analysis operation is performed on the target event document to obtain structured data. The preset analysis operation includes a first analysis operation based on regular matching and a second analysis operation based on an entity recognition model of natural language processing. A dynamic mapping relationship table of the engineering change notification event and diagnostic resources is established, and integrity verification is performed. If the integrity verification is passed, the diagnostic resources are downloaded to a diagnostic test system of the storage device. Whether there is a version conflict between a current device firmware version of the storage device and a required device firmware version is judged, so that the diagnostic test system performs diagnostic testing on the storage device based on the diagnostic resources when there is no version conflict, the situation that a factory diagnosis test is stopped due to untimely maintenance is avoided, and the efficiency and accuracy of storage maintenance are improved.

The present invention is directed to olfactory diagnostic testing compositions and kits for detecting, screening and / or monitoring the progression of specific disease states or other conditions in a subject. In one aspect, the invention is directed to a method and testing kit using a pathology-specific panel of fragrances to detect, screen and / or monitor a specific disease state or condition. In another aspect, the invention is directed to a method of making diagnostic compositions having a specific complex fragrance such as an essential oil fragrance and diagnostic testing kits including such diagnostic compositions.

To provide a method and device for analyzing non-volatile organic substances in exhaled breath. [Solution] A method and device for analyzing non-volatile organic compounds in exhaled breath and other aerosols is disclosed, using a variety of diagnostic tools that enable rapid, low-cost point-of-care assays for several diseases, including respiratory diseases such as COVID-19. The disclosed method and system selectively captures non-volatile organic compounds in exhaled breath and other aerosols in a packed bed column. The non-volatile organic compounds are eluted, and the sample is analyzed using a diagnostic instrument, including MALDI-TOFMS. The disclosed system and method provide diagnostic test results in less than approximately 20 minutes and enable autonomous operation with minimal human intervention.

A method for estimating a number of phagocytes in a body fluid of an animal includes stimulating NADPH oxidase activity of the phagocytes; and quantifying a resulting reductive dioxygenation of a chemiluminigenic substrate by an emitted chemiluminescence of the chemiluminigenic substrate using an instrument capable of measuring light. The NADPH oxidase activity of the phagocytes is preferably stimulated by an immunologic or chemical capable of activating a respiratory burst by the phagocytes. The NADPH oxidase activity of the phagocytes is preferably stimulated by a stimulus in solution or coated to a surface contacted by the phagocytes. The stimulus is preferably phorbol myristate acetate (PMA). The animal is preferably human, and the body fluid is preferably blood and / or spinal fluid. The phagocytes are preferably neutrophil leukocytes, and the chemiluminigenic substrate is preferably lucigenin (N,N′-dimethyl-9,9′-biacridinium dinitrate). Also provided is a method of treatment based on the estimation method.

Methods and apparatus for automatically determining a diagnostic test result from a lateral flow assay are provided. The method comprises receiving at least one image of the lateral flow assay, identifying, with a hardware computer processor, a view window in the at least one image, determining, within the identified view window, a first signal strength for a control line and a second signal strength for one or more test lines, determining the diagnostic test result based on the first signal strength and / or the second signal strength, and outputting an indication of the diagnostic test result.

The present disclosure relates to a storage device for an automated diagnostic testing system and an automated diagnostic testing system including the same. More particularly, the storage device includes a storage area configured to store materials, an identification information reader, a material dispensing interface configured to interact with a transfer device of the automated diagnostic testing system, and a controller configured to control the storage device, wherein the controller determines, based on identification information of a sample loaded in the automated diagnostic testing system, materials to be supplied to a functional device, and controls the storage device such that the determined materials are supplied to the functional device.

Systems and methods for integration of user-administered diagnostic test results with electronic health records are provided. In one aspect, a method includes receiving a prescription specifying a user-administered test and a patient, transmitting prescription information to a pharmacy and to the test provider, generating a unique order identifier which is sent to a user application that associates the order identifier with a test result after the user administers the test, receiving the test result in association with the order identifier, storing the test result and the order identifier in a medical record database in association with a medical record number or a consultation identifier, and sending a notification of the test result to the prescribing clinician.

The invention relates to application of a myocardial injury marker RSPO1 in preparation of a product for identifying cardiovascular diseases. The invention evaluates the expression profiles of all LGR4 ligands under cardiovascular diseases at present, provides the application of RSPO1 as a potential drug target, and further provides the application of the myocardial injury marker RSPO1 in preparation of products for identifying cardiovascular diseases based on the application. The invention also provides application of the reagent for detecting the RSPO1 protein level in preparation of products for diagnosing cardiovascular diseases. According to the invention, the problem of insufficient adaptability and specificity of the existing marker is solved, RSPO1 is developed into a diagnostic marker, a DY4645-05 ELISA kit is adopted for detection and adaptation of multiple samples such as serum, multiple cardiovascular diseases can be diagnosed, cross-species application is realized, a basic research and clinical diagnosis detection system is unified, and powerful support is provided for diagnosis and treatment of cardiovascular diseases.

A diagnostic testing device is a testing-device for immunochromatography wherein a liquid sample contains an analyte developed in a detection area via a labeling-substance-containing area of a test strip, and a negative or positive interpretation is made from the coloration exhibited by the detection area. The device includes a measuring part for obtaining data on a coloration index associated with coloration state for at least part of the detection area, and a processing part that interprets based on the coloration index data. The processing part delivers a negative interpretation if the coloration state of the analyte detection area is in a negative state in at least one image out of a maximum of N (wherein N is greater than 1) obtained images, and delivers a positive assessment if the coloration state of the analyte detection area is in a positive state in all N images.

This invention relates to the field of automotive technology and discloses a vehicle diagnostic method, device, and storage medium for vehicles with separate upper and lower body panels. The vehicle diagnostic method determines whether the suppliers of the upper and lower body panels are the same to provide corresponding diagnostic methods. If the suppliers of the upper and lower body panels are the same, the diagnosis of both upper and lower body panels is achieved through a first gateway; if the suppliers of the upper and lower body panels are different, the diagnosis of both upper and lower body panels is achieved through both the first gateway and a second gateway. This invention fulfills the diagnostic requirements for vehicles with separate upper and lower body panels; simultaneously, it provides a complete diagnostic system for emerging electric vehicle manufacturers without experience in whole-vehicle development, covering diagnostic implementation at the vehicle end, and diagnostic testing needs from engineering to after-sales service.

Neural stimulation assemblies, systems, and methods enable short-term therapy or diagnostic testing to be provided by providing an electrical connection between a muscle and / or a nerve within a body and a stimulator and / or a recorder mounted on a skin surface or carried outside the body. The assemblies provide maximum patient mobility and comfort through differentiated components that have minimal profile and are connected through detachable and adjustable connections.

1. Name of the product in this design: Calibration and calibration plate (ADAS). 2. Purpose of this design: To be attached to the surface of vehicle glass to assist advanced driver assistance systems in diagnostic testing and calibration. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: a 3D model.

The disclosed diagnostic test cartridges collect a controlled amount of a patient sample using a capillary slide. The capillary slide mates with a capillary channel to cause diluent to mix in a controlled manner with the patient sample to prepare it for further processing, such as sonication and diagnostic testing. The cartridge can be a two-part design in some examples that selectively couple together to cause the patient sample to be collected in a controlled manner and the diluent to be released to mix with the patient sample in a controlled manner to improve the quality of the prepared sample for diagnostic testing.

Testing methods and systems provide a Diagnostic Testing Service as well as an attack simulation service, for a perimeter security system, in a non-disruptive manner, so that the production targets can be tested while normally functioning, and do not have to be brought down for testing. The testing methods can be implemented, such that they are vendor and device type neutral, considering the overall strategy utilized to prevent perimeter security system attacks.

According to one embodiment, a method for sharing diagnostic data is provided, the method, performed by a computer device, including a step of receiving first diagnostic test results from a terminal of a user, the first diagnostic test results being stored in a database of the computer device, and a step of granting sharing authority to the user on the basis of the availability of data included in the first diagnostic test results, wherein the sharing authority is used to determine the use conditions of shared data so that the user can receive balanced and / or conditional sharing of shared data including second diagnostic test results of another user previously stored in the database.